ArticleClinical cardiology2015
Assessing the Quality of Care for Patients With Acute Myocardial Infarction in China.
Article in Clinical cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review.Heart Asia · 2019Pooled it
- Management of acute coronary syndrome in resource-limited set up: a summary of 4-year review of two hospitals in Ethiopia.Frontiers in cardiovascular medicine · 2025Article
- Acute coronary syndrome and its treatment outcomes in Ethiopia: a systematic review and meta-analysis.Journal of pharmaceutical policy and practice · 2023Review
- Article
- Article
- Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction.Frontiers in cardiovascular medicine · 2020Article
- Quality of Care for Patients with Acute Myocardial Infarction (AMI) in Pakistan: A Retrospective Study.International journal of environmental research and public health · 2019Article
- Association Between Medication Adherence and 1-Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China.Journal of the American Heart Association · 2019Article
- Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing.BMC health services research · 2019Article
- Factors that contribute to poor adherence to statin therapy in coronary heart disease patients from Chongqing and measures to improve their therapeutic outcomes.Genes & diseases · 2018Article
- The development of indicator measure for monitoring the quality of patient-centered care in China's tertiary hospitals.PloS one · 2018Article
- Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.Journal of cellular and molecular medicine · 2017Article
- The Contemporary Use of Angiography and Revascularization Among Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States Compared With South Korea.Clinical cardiology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a wide practice gap between optimal care and actual care for patients with acute myocardial infarction (AMI) in China. Indicators of quality of care for AMI patients have already been developed by a modified Delphi process. Our aim was to assess the association between those indicators and in-hospital mortality in AMI patients. We hypothesized that an association exists between quality-of-care indicators and in-hospital mortality in AMI patients. Based on the data of 2128 AMI patients at 20 tertiary hospitals in Heilongjiang Province from January 1, 2009 to October 31, 2010, we estimated the compliance rates of indicators. Association between indicators and in-hospital mortality was assessed using hierarchical generalized linear models. Among 2128 patients, 163 (7.66%) died during their hospital stay. The compliance rates were 71.6%, 41.3%, 82.5%, 63.5%, 80.4%, 5.1%, 28.9%, and 41.2% for the use of aspirin, β-blocker, clopidogrel, angiotensin-converting enzyme inhibitor, statin, thrombolytic, percutaneous coronary intervention, and coronary angiography, respectively. Aspirin, clopidogrel, angiotensin-converting enzyme inhibitor, statin, and percutaneous coronary intervention were significantly associated with in-hospital mortality after adjustment for potential confounding factors. We found some disparities between guidelines and clinical practice for AMI patients in China and a significant association between indicators and in-hospital mortality. Our findings are potentially helpful for assessing and improving the quality of care for AMI patients in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.